← Every company
Sarepta Therapeutics Inc SEC Filings
What Sarepta Therapeutics Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
SRPT overview →Filings on file
116
since Oct 4, 2016
Warning signs
0
none filed
Last results
Aug 5, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Jul 27, 2026 | Executive or director change 8-K | Read ↗ |
| Jun 4, 2026 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Feb 25, 2026 | Executive or director change 8-K | Read ↗ |
| Dec 8, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 13, 2025 | Executive or director change 8-K | Read ↗ |
| Jul 16, 2025 | Executive or director changeResults announcedRestructuring 8-K | Read ↗ |
| Jun 6, 2025 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Sep 16, 2024 | Executive or director change 8-K | Read ↗ |
| Jun 7, 2024 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Jun 9, 2023 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Nov 2, 2022 | Executive or director change 8-K | Read ↗ |
| Jun 3, 2022 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Apr 21, 2022 | Executive or director change 8-K | Read ↗ |
| Apr 5, 2022 | Executive or director change 8-K | Read ↗ |
| Nov 17, 2021 | Executive or director change 8-K | Read ↗ |
| Dec 14, 2020 | Executive or director change 8-K | Read ↗ |
| Aug 5, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 30, 2020 | Executive or director change 8-K | Read ↗ |
| Jun 8, 2020 | Executive or director changeShareholder vote 8-K | Read ↗ |
| Mar 19, 2020 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2020 | Executive or director change 8-K | Read ↗ |
| Jan 13, 2020 | Executive or director changeResults announced 8-K | Read ↗ |
| Mar 5, 2019 | Executive or director change 8-K | Read ↗ |
| Dec 11, 2018 | Executive or director change 8-K | Read ↗ |
| Aug 1, 2018 | Executive or director change 8-K | Read ↗ |
| Jun 27, 2018 | Executive or director change 8-K | Read ↗ |
| Dec 5, 2017 | Executive or director change 8-K | Read ↗ |
| Aug 17, 2017 | Executive or director change 8-K | Read ↗ |
| Jun 28, 2017 | Executive or director change 8-K | Read ↗ |
| Apr 27, 2017 | Executive or director change 8-K | Read ↗ |
Source: Sarepta Therapeutics Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on SRPT
Company overviewEverything on SRPT in one place, with the price.Insider tradingWhat SRPT's own officers and directors buy and sell.Executive payWhat SRPT awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in SRPT.Funds holding itWhich funds and ETFs hold SRPT, and how big a bet.LobbyingWhat SRPT spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on SRPT's account, and who they worked for.PatentsWhat SRPT is filing at the patent office.